Literature DB >> 26188076

The TNF-family cytokine TL1A: from lymphocyte costimulator to disease co-conspirator.

Arianne C Richard1, John R Ferdinand1, Françoise Meylan1, Erika T Hayes1, Odile Gabay1, Richard M Siegel2.   

Abstract

Originally described in 2002 as a T cell-costimulatory cytokine, the tumor necrosis factor family member TNF-like factor 1A (TL1A), encoded by the TNFSF15 gene, has since been found to affect multiple cell lineages through its receptor, death receptor 3 (DR3, encoded by TNFRSF25) with distinct cell-type effects. Genetic deficiency or blockade of TL1A-DR3 has defined a number of disease states that depend on this cytokine-receptor pair, whereas excess TL1A leads to allergic gastrointestinal inflammation through stimulation of group 2 innate lymphoid cells. Noncoding variants in the TL1A locus are associated with susceptibility to inflammatory bowel disease and leprosy, predicting that the level of TL1A expression may influence host defense and the development of autoimmune and inflammatory diseases. © Society for Leukocyte Biology.

Entities:  

Keywords:  DR3; autoimmune disease

Mesh:

Substances:

Year:  2015        PMID: 26188076      PMCID: PMC4763597          DOI: 10.1189/jlb.3RI0315-095R

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  126 in total

1.  IL-1 serves as a secondary signal for IL-9 expression.

Authors:  E Schmitt; H U Beuscher; C Huels; P Monteyne; R van Brandwijk; J van Snick; E Ruede
Journal:  J Immunol       Date:  1991-12-01       Impact factor: 5.422

2.  TLR8-mediated activation of human monocytes inhibits TL1A expression.

Authors:  Masayuki Saruta; Kathrin S Michelsen; Lisa S Thomas; Qi T Yu; Carol J Landers; Stephan R Targan
Journal:  Eur J Immunol       Date:  2009-08       Impact factor: 5.532

3.  A genome-wide association study identifies 2 susceptibility Loci for Crohn's disease in a Japanese population.

Authors:  Keiko Yamazaki; Junji Umeno; Atsushi Takahashi; Atsushi Hirano; Todd Andrew Johnson; Natsuhiko Kumasaka; Takashi Morizono; Naoya Hosono; Takaaki Kawaguchi; Masakazu Takazoe; Tetsuhiro Yamada; Yasuo Suzuki; Hiroki Tanaka; Satoshi Motoya; Masayo Hosokawa; Yoshiaki Arimura; Yasuhisa Shinomura; Toshiyuki Matsui; Takayuki Matsumoto; Mitsuo Iida; Tatsuhiko Tsunoda; Yusuke Nakamura; Naoyuki Kamatani; Michiaki Kubo
Journal:  Gastroenterology       Date:  2012-12-22       Impact factor: 22.682

4.  Triggering of TNFRSF25 promotes CD8⁺ T-cell responses and anti-tumor immunity.

Authors:  Tomasz J Slebioda; Tania F Rowley; John R Ferdinand; Jane E Willoughby; Sarah L Buchan; Vadim Y Taraban; Aymen Al-Shamkhani
Journal:  Eur J Immunol       Date:  2011-08-04       Impact factor: 5.532

5.  HLA-Cw*1202-B*5201-DRB1*1502 haplotype increases risk for ulcerative colitis but reduces risk for Crohn's disease.

Authors:  Yukinori Okada; Keiko Yamazaki; Junji Umeno; Atsushi Takahashi; Natsuhiko Kumasaka; Kyota Ashikawa; Tomomi Aoi; Masakazu Takazoe; Toshiyuki Matsui; Atsushi Hirano; Takayuki Matsumoto; Naoyuki Kamatani; Yusuke Nakamura; Kazuhiko Yamamoto; Michiaki Kubo
Journal:  Gastroenterology       Date:  2011-07-19       Impact factor: 22.682

6.  Apoptosis of dendritic cells induced by decoy receptor 3 (DcR3).

Authors:  Ren-In You; Yung-Chi Chang; Po-Min Chen; Wei-Shu Wang; Tsui-Ling Hsu; Chih-Ya Yang; Chun-Ting Lee; Shie-Liang Hsieh
Journal:  Blood       Date:  2007-11-15       Impact factor: 22.113

7.  Loci on 20q13 and 21q22 are associated with pediatric-onset inflammatory bowel disease.

Authors:  Subra Kugathasan; Robert N Baldassano; Jonathan P Bradfield; Patrick M A Sleiman; Marcin Imielinski; Stephen L Guthery; Salvatore Cucchiara; Cecilia E Kim; Edward C Frackelton; Kiran Annaiah; Joseph T Glessner; Erin Santa; Tara Willson; Andrew W Eckert; Erin Bonkowski; Julie L Shaner; Ryan M Smith; F George Otieno; Nicholas Peterson; Debra J Abrams; Rosetta M Chiavacci; Robert Grundmeier; Petar Mamula; Gitit Tomer; David A Piccoli; Dimitri S Monos; Vito Annese; Lee A Denson; Struan F A Grant; Hakon Hakonarson
Journal:  Nat Genet       Date:  2008-08-31       Impact factor: 38.330

8.  The TNF-family cytokine TL1A drives IL-13-dependent small intestinal inflammation.

Authors:  F Meylan; Y-J Song; I Fuss; S Villarreal; E Kahle; I-J Malm; K Acharya; H L Ramos; L Lo; M M Mentink-Kane; T A Wynn; T-S Migone; W Strober; R M Siegel
Journal:  Mucosal Immunol       Date:  2010-10-27       Impact factor: 7.313

9.  The transcription factor PU.1 is required for the development of IL-9-producing T cells and allergic inflammation.

Authors:  Hua-Chen Chang; Sarita Sehra; Ritobrata Goswami; Weiguo Yao; Qing Yu; Gretta L Stritesky; Rukhsana Jabeen; Carl McKinley; Ayele-Nati Ahyi; Ling Han; Evelyn T Nguyen; Michael J Robertson; Narayanan B Perumal; Robert S Tepper; Stephen L Nutt; Mark H Kaplan
Journal:  Nat Immunol       Date:  2010-05-02       Impact factor: 25.606

10.  Human CD4 memory T cells can become CD4+IL-9+ T cells.

Authors:  Prabhakar Putheti; Amit Awasthi; Joyce Popoola; Wenda Gao; Terry B Strom
Journal:  PLoS One       Date:  2010-01-14       Impact factor: 3.240

View more
  29 in total

Review 1.  The Tumor Necrosis Factor Family: Family Conventions and Private Idiosyncrasies.

Authors:  David Wallach
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-10-01       Impact factor: 10.005

Review 2.  TNF superfamily cytokines in the promotion of Th9 differentiation and immunopathology.

Authors:  Françoise Meylan; Richard M Siegel
Journal:  Semin Immunopathol       Date:  2016-11-28       Impact factor: 9.623

Review 3.  Beyond TNF: TNF superfamily cytokines as targets for the treatment of rheumatic diseases.

Authors:  Michael Croft; Richard M Siegel
Journal:  Nat Rev Rheumatol       Date:  2017-03-09       Impact factor: 20.543

4.  Microbiota-Induced TNF-like Ligand 1A Drives Group 3 Innate Lymphoid Cell-Mediated Barrier Protection and Intestinal T Cell Activation during Colitis.

Authors:  Jim G Castellanos; Viola Woo; Monica Viladomiu; Gregory Putzel; Svetlana Lima; Gretchen E Diehl; Andrew R Marderstein; Jorge Gandara; Alexendar R Perez; David R Withers; Stephan R Targan; David Q Shih; Ellen J Scherl; Randy S Longman
Journal:  Immunity       Date:  2018-12-11       Impact factor: 31.745

5.  Interleukin 33 and interleukin 4 regulate interleukin 31 gene expression and secretion from human laboratory of allergic diseases 2 mast cells stimulated by substance P and/or immunoglobulin E.

Authors:  Anastasia I Petra; Irene Tsilioni; Alexandra Taracanova; Alexandra Katsarou-Katsari; Theoharis C Theoharides
Journal:  Allergy Asthma Proc       Date:  2018-03-01       Impact factor: 2.587

6.  Death receptor 3 mediates necroptotic cell death.

Authors:  Sebastian Bittner; Gertrud Knoll; Martin Ehrenschwender
Journal:  Cell Mol Life Sci       Date:  2016-09-03       Impact factor: 9.261

7.  SP and IL-33 together markedly enhance TNF synthesis and secretion from human mast cells mediated by the interaction of their receptors.

Authors:  Alexandra Taracanova; Mihail Alevizos; Anna Karagkouni; Zuiy Weng; Errol Norwitz; Pio Conti; Susan E Leeman; Theoharis C Theoharides
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-01       Impact factor: 11.205

Review 8.  Progranulin: A key player in autoimmune diseases.

Authors:  Jinlong Jian; Guangfei Li; Aubryanna Hettinghouse; Chuanju Liu
Journal:  Cytokine       Date:  2016-08-12       Impact factor: 3.861

9.  TL1A Promotes Lung Tissue Fibrosis and Airway Remodeling.

Authors:  Rana Herro; Haruka Miki; Gurupreet S Sethi; David Mills; Amit Kumar Mehta; Xinh-Xinh Nguyen; Carol Feghali-Bostwick; Marina Miller; David H Broide; Rachel Soloff; Michael Croft
Journal:  J Immunol       Date:  2020-09-21       Impact factor: 5.422

10.  Cleavage of TL1A Differentially Regulates Its Effects on Innate and Adaptive Immune Cells.

Authors:  John R Ferdinand; Arianne C Richard; Françoise Meylan; Aymen Al-Shamkhani; Richard M Siegel
Journal:  J Immunol       Date:  2018-01-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.